| 000 | 01572 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518044257.0 | ||
| 264 | 0 | _c20200717 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00705-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aViljoen, Albertus | |
| 245 | 0 | 0 |
_aVerapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c09 2019 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDiarylquinolines _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacrophages _xmicrobiology |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdrug therapy |
| 650 | 0 | 4 |
_aMycobacterium abscessus _xdrug effects |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aRaynaud, Clément | |
| 700 | 1 | _aJohansen, Matt D | |
| 700 | 1 | _aRoquet-Banères, Françoise | |
| 700 | 1 | _aHerrmann, Jean-Louis | |
| 700 | 1 | _aDaher, Wassim | |
| 700 | 1 | _aKremer, Laurent | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 63 _gno. 9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00705-19 _zAvailable from publisher's website |
| 999 |
_c29808013 _d29808013 |
||